The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or when to resign.

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

Recent health news highlights include Kenvue cutting its sales forecast amid strategic changes, Eli Lilly raising its profit ...

Children with moderate/more extensive atopic dermatitis treated with ruxolitinib cream achieved significant disease control ...

So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

Trump told CNBC he will initially impose a “small tariff” on pharmas in the next week or so, but will raise it to 150% in a ...

Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

Clinical research centers across the US, including the Jacksonville Center for Clinical Research, are being impacted by the ...